Related Experiment Video
Updated: Jun 18, 2025

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
Cardiotoxicity as a Possible Side Effect of Statins
Aleksey Chaulin1,2,3
1Department of Histology and Embryology, Samara State Medical University, 443099 Samara, Samara Region, Russia.
Insights
Statins offer cardiovascular benefits but may cause side effects, including potential cardiotoxicity. Further research is needed to understand these risks and optimize patient care.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Statins are widely used for cardiovascular disease prevention and management, exhibiting various lipid and non-lipid beneficial effects.
- Contradictory findings exist regarding some of statins' benefits, and known side effects like myotoxicity and hepatotoxicity can limit their use.
- Recent studies raise concerns about statin-induced cardiotoxicity, evidenced by increased cardiac troponin levels.
Purpose of the Study:
- To discuss the potential mechanisms underlying statin-induced cardiotoxicity.
- To outline future research directions in this critical area.
Main Methods:
- Review of current literature on statin mechanisms and effects.
- Analysis of studies reporting on statin cardiotoxicity and cardiac biomarker changes.
Main Results:
- Statins possess both beneficial and potentially harmful cardiovascular effects.
- Evidence suggests statins may contribute to cardiotoxicity, indicated by elevated highly sensitive cardiac troponins (hs-cTns).
Conclusions:
- The potential cardiotoxicity of statins requires detailed investigation into underlying mechanisms.
- Further research is essential to clarify the risks and benefits of statins, particularly concerning cardiac health.
Abstract:
According to current views, statins have a wide range of beneficial effects (lipid and non-lipid) on the cardiovascular system, so they are one of the most commonly used drugs for the prevention and management of patients with cardiovascular diseases. However, it is important to note that information about many beneficial effects of statins is contradictory. In addition, a number of side effects of statins, in particular, myotoxicity, hepatotoxicity, diabetogenic property, etc., may limit the possibility of using statins or even force doctors to cancel these drugs. Also, some concerns are caused by recent studies reporting cardiotoxicity of statins and increased serum concentrations of biomarkers of myocardial damage (highly sensitive cardiac troponins (hs-cTns)) in patients taking statins. This article discusses in detail the possible mechanisms of cardiotoxicity of statins and outlines the directions for further research in this area.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Heart Failure Drugs: Inotropic Agents
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

